Resultados de búsqueda - Michael Polydefkis
- Mostrando 1 - 20 Resultados de 51
- Ir a la Siguiente Página
-
1
-
2
-
3
-
4
-
5
Assessment of Epidermal Nerve Fibers por Gigi J. Ebenezer, Peter Hauer, Christopher H. Gibbons, Justin C. McArthur, Michael Polydefkis
Publicado 2007Revisão -
6
-
7
-
8
The time course of epidermal nerve fibre regeneration: studies in normal controls and in people with diabetes, with and without neuropathy por Michael Polydefkis, Peter Hauer, Soham Sheth, Michael Sirdofsky, John W. Griffin, Justin C. McArthur
Publicado 2004Artigo -
9
-
10
-
11
Diagnosis and treatment of hereditary transthyretin amyloidosis with polyneuropathy in the <scp>United States</scp>: <scp>Recommendations</scp> from a panel of experts por Chafic Karam, Michelle L. Mauermann, Alejandra González‐Duarte, Michelle Kaku, Senda Ajroud‐Driss, Thomas H. Brannagan, Michael Polydefkis
Publicado 2024Artigo -
12
-
13
Treatment response and neurofilament light chain levels with long-term patisiran in hereditary transthyretin-mediated amyloidosis with polyneuropathy: 24-month results of an open-l... por Simina Ticau, Emre Aldinc, Michael Polydefkis, David Adams, Teresa Coelho, Mitsuharu Ueda, Cecilia Hale, Joshua R. Vest, Paul Nioi
Publicado 2023Artigo -
14
Development of measures of polyneuropathy impairment in hATTR amyloidosis: From NIS to mNIS + 7 por P. James B. Dyck, Alejandra González‐Duarte, Laura Obici, Michael Polydefkis, Janice F. Wiesman, Ilia Antonino, William J. Litchy, P. James B. Dyck
Publicado 2019Revisão -
15
-
16
LepVax, a defined subunit vaccine that provides effective pre-exposure and post-exposure prophylaxis of M. leprae infection por Malcolm S. Duthie, Maria T. Peña, Gigi J. Ebenezer, Thomas P. Gillis, Rahul Sharma, Kelly Cunningham, Michael Polydefkis, Yumi Maeda, Masahiko Makino, Richard W. Truman, Steven G. Reed
Publicado 2018Artigo -
17
-
18
Evaluation of disease progression in patients with ATTR amyloidosis with cardiomyopathy following treatment with patisiran: post-hoc analysis of the APOLLO-B study por Thibaud Damy, Zubair Shah, Brian Drachman, Pedro Vellosa Schwartzmann, Cláudio Tinoco Mesquita, Michael Polydefkis, Laura Obici, Patrick Y. Jay, Shaun Bender, Kelley E. Capocelli, Mazen Hanna
Publicado 2023Artigo -
19
Race and Socioeconomic Status Impact Diagnosis and Clinical Outcomes in Transthyretin Cardiac Amyloidosis por Bairavi Shankar, Lisa R. Yanek, Artrish Jefferson, Vivek Jani, Emily Brown, Daniel Tsottles, Jennifer Barranco, Serena Zampino, Mark J. Ranek, Kavita Sharma, Michael Polydefkis, Joban Vaishnav
Publicado 2024Artigo -
20
Comparison of efficacy outcomes with Vutrisiran vs. Patisiran in hATTR amyloidosis with polyneuropathy: post-hoc analysis of the HELIOS-A study por Michael Polydefkis, Frank Birklein, Yoshiki Sekijima, Davide Pareyson, Márcia Waddington‐Cruz, Raphael Santa Rosa Sayegh, David Danese, Kelley E. Capocelli, Madeline Merkel, Chongshu Chen, Joshua R. Vest, David Adams
Publicado 2023Artigo
Herramientas de búsqueda:
Materias Relacionadas
Medicine
Internal medicine
Amyloidosis
Transthyretin
Polyneuropathy
Pathology
Endocrinology
Biology
Gastroenterology
Surgery
Diabetes mellitus
Disease
Nursing
Physical therapy
Quality of life (healthcare)
Alternative medicine
Anatomy
Neuroscience
Peripheral neuropathy
Placebo
Anesthesia
Clinical trial
Gene
Genetics
Oncology
Psychiatry
Biochemistry
Biopsy
Confidence interval
Environmental health